630 related articles for article (PubMed ID: 23283493)
1. Injection of vessel-derived stem cells prevents dilated cardiomyopathy and promotes angiogenesis and endogenous cardiac stem cell proliferation in mdx/utrn-/- but not aged mdx mouse models for duchenne muscular dystrophy.
Chun JL; O'Brien R; Song MH; Wondrasch BF; Berry SE
Stem Cells Transl Med; 2013 Jan; 2(1):68-80. PubMed ID: 23283493
[TBL] [Abstract][Full Text] [Related]
2. Nestin expression in end-stage disease in dystrophin-deficient heart: implications for regeneration from endogenous cardiac stem cells.
Berry SE; Andruszkiewicz P; Chun JL; Hong J
Stem Cells Transl Med; 2013 Nov; 2(11):848-61. PubMed ID: 24068741
[TBL] [Abstract][Full Text] [Related]
3. Dystrophin Deficiency Causes Progressive Depletion of Cardiovascular Progenitor Cells in the Heart.
Jelinkova S; Sleiman Y; Fojtík P; Aimond F; Finan A; Hugon G; Scheuermann V; Beckerová D; Cazorla O; Vincenti M; Amedro P; Richard S; Jaros J; Dvorak P; Lacampagne A; Carnac G; Rotrekl V; Meli AC
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34068508
[TBL] [Abstract][Full Text] [Related]
4. Multipotential mesoangioblast stem cell therapy in the mdx/utrn-/- mouse model for Duchenne muscular dystrophy.
Berry SE; Liu J; Chaney EJ; Kaufman SJ
Regen Med; 2007 May; 2(3):275-88. PubMed ID: 17511564
[TBL] [Abstract][Full Text] [Related]
5. Cardiac dysfunction and pathology in the dystrophin and utrophin-deficient mouse during development of dilated cardiomyopathy.
Chun JL; O'Brien R; Berry SE
Neuromuscul Disord; 2012 Apr; 22(4):368-79. PubMed ID: 22266080
[TBL] [Abstract][Full Text] [Related]
6. Cardiac Protection after Systemic Transplant of Dystrophin Expressing Chimeric (DEC) Cells to the mdx Mouse Model of Duchenne Muscular Dystrophy.
Siemionow M; Malik M; Langa P; Cwykiel J; Brodowska S; Heydemann A
Stem Cell Rev Rep; 2019 Dec; 15(6):827-841. PubMed ID: 31612351
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular phenotype of the
Szabó PL; Ebner J; Koenig X; Hamza O; Watzinger S; Trojanek S; Abraham D; Todt H; Kubista H; Schicker K; Remy S; Anegon I; Kiss A; Podesser BK; Hilber K
Dis Model Mech; 2021 Feb; 14(2):. PubMed ID: 33619211
[TBL] [Abstract][Full Text] [Related]
8. Skeletal muscle fibrosis in the mdx/utrn+/- mouse validates its suitability as a murine model of Duchenne muscular dystrophy.
Gutpell KM; Hrinivich WT; Hoffman LM
PLoS One; 2015; 10(1):e0117306. PubMed ID: 25607927
[TBL] [Abstract][Full Text] [Related]
9. Increased constitutive nitric oxide production by whole body periodic acceleration ameliorates alterations in cardiomyocytes associated with utrophin/dystrophin deficiency.
Lopez JR; Kolster J; Zhang R; Adams J
J Mol Cell Cardiol; 2017 Jul; 108():149-157. PubMed ID: 28623080
[TBL] [Abstract][Full Text] [Related]
10. Lifelong quercetin enrichment and cardioprotection in Mdx/Utrn+/- mice.
Ballmann C; Denney TS; Beyers RJ; Quindry T; Romero M; Amin R; Selsby JT; Quindry JC
Am J Physiol Heart Circ Physiol; 2017 Jan; 312(1):H128-H140. PubMed ID: 27836895
[TBL] [Abstract][Full Text] [Related]
11. Comparison of skeletal muscle pathology and motor function of dystrophin and utrophin deficient mouse strains.
van Putten M; Kumar D; Hulsker M; Hoogaars WM; Plomp JJ; van Opstal A; van Iterson M; Admiraal P; van Ommen GJ; 't Hoen PA; Aartsma-Rus A
Neuromuscul Disord; 2012 May; 22(5):406-17. PubMed ID: 22284942
[TBL] [Abstract][Full Text] [Related]
12. Improved mitochondrial function in the hearts of sarcolipin-deficient dystrophin and utrophin double-knockout mice.
Mareedu S; Fefelova N; Galindo CL; Prakash G; Mukai R; Sadoshima J; Xie LH; Babu GJ
JCI Insight; 2024 Apr; 9(9):. PubMed ID: 38564291
[TBL] [Abstract][Full Text] [Related]
13. Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy.
Siemionow M; Langa P; Brodowska S; Kozlowska K; Zalants K; Budzynska K; Heydemann A
Stem Cell Rev Rep; 2022 Dec; 18(8):2872-2892. PubMed ID: 35590083
[TBL] [Abstract][Full Text] [Related]
14. Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice.
Su X; Shen Y; Jin Y; Jiang M; Weintraub N; Tang Y
J Vis Exp; 2019 Apr; (146):. PubMed ID: 31033952
[TBL] [Abstract][Full Text] [Related]
15. Small Fractions of Muscular Dystrophy Embryonic Stem Cells Yield Severe Cardiac and Skeletal Muscle Defects in Adult Mouse Chimeras.
Gonzalez JP; Kyrychenko S; Kyrychenko V; Schneider JS; Granier CJ; Himelman E; Lahey KC; Zhao Q; Yehia G; Tao YX; Bhaumik M; Shirokova N; Fraidenraich D
Stem Cells; 2017 Mar; 35(3):597-610. PubMed ID: 27734557
[TBL] [Abstract][Full Text] [Related]
16. Ifetroban reduces coronary artery dysfunction in a mouse model of Duchenne muscular dystrophy.
Mitchell R; Frederick NE; Holzman ER; Agobe F; Allaway HCM; Bagher P
Am J Physiol Heart Circ Physiol; 2021 Jul; 321(1):H52-H58. PubMed ID: 34048282
[TBL] [Abstract][Full Text] [Related]
17. Transplantation of Dystrophin Expressing Chimeric Human Cells of Myoblast/Mesenchymal Stem Cell Origin Improves Function in Duchenne Muscular Dystrophy Model.
Siemionow M; Szilagyi E; Cwykiel J; Domaszewska-Szostek A; Heydemann A; Garcia-Martinez J; Siemionow K
Stem Cells Dev; 2021 Feb; 30(4):190-202. PubMed ID: 33349121
[TBL] [Abstract][Full Text] [Related]
18. Exosome-Mediated Benefits of Cell Therapy in Mouse and Human Models of Duchenne Muscular Dystrophy.
Aminzadeh MA; Rogers RG; Fournier M; Tobin RE; Guan X; Childers MK; Andres AM; Taylor DJ; Ibrahim A; Ding X; Torrente A; Goldhaber JM; Lewis M; Gottlieb RA; Victor RA; Marbán E
Stem Cell Reports; 2018 Mar; 10(3):942-955. PubMed ID: 29478899
[TBL] [Abstract][Full Text] [Related]
19. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
20. Low dystrophin levels increase survival and improve muscle pathology and function in dystrophin/utrophin double-knockout mice.
van Putten M; Hulsker M; Young C; Nadarajah VD; Heemskerk H; van der Weerd L; 't Hoen PA; van Ommen GJ; Aartsma-Rus AM
FASEB J; 2013 Jun; 27(6):2484-95. PubMed ID: 23460734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
